Pa. Brex et al., Measurement of spinal cord area in clinically isolated syndromes suggestive of multiple sclerosis, J NE NE PSY, 70(4), 2001, pp. 544-547
Atrophy of the spinal cord is known to occur in multiple sclerosis but the
cause and the timing of its onset are not clear. Recent evidence suggests t
hat atrophy may start to occur early in the disease. The aim was to determi
ne whether atrophy of the spinal cord could be detected in vivo using MRI t
echniques, in patients presenting with a clinically isolated syndrome, whic
h in many cases is the earliest clinical stage of multiple sclerosis.
The cross sectional area of the spinal cord was measured in 43 patients pre
senting with a clinically isolated syndrome and 15 matched controls. T2 wei
ghted imaging of the brain was also performed to determine the number and v
olume of high signal lesions consistent with disseminated demyelination. Bo
th patients and controls were restudied after 1 year.
The spinal cord area was significantly smaller in the 74% of patients with
an abnormal brain MRI at presentation than in controls (mean areas 73.9 mm(
2) and 78.1 mm(2) respectively, p=0.03). No significant difference was foun
d in the spinal cord area between controls and patients with normal baselin
e brain imaging. The annual rate of change in patients did not differ signi
ficantly from controls.
In conclusion, the finding of a smaller cord area in the subgroup of patien
ts with clinically isolated syndrome with the highest risk of developing mu
ltiple sclerosis-that is, with an abnormal brain MRI, suggests that atrophy
has developed in some patients with multiple sclerosis even before their f
irst clinical symptoms. However, the lack of a detectable change in cord ar
ea over 1 year of follow up contrasts strikingly with the results of an ear
lier study of patients with relapsing-remitting multiple sclerosis, suggest
ing that the rate of atrophy increases as the disease becomes more establis
hed.